Topical cyclosporin in oral lichen planus: a controlled, randomized, prospective trial

Br J Dermatol. 1995 May;132(5):790-4. doi: 10.1111/j.1365-2133.1995.tb00728.x.

Abstract

The published studies of topical cyclosporin (CyA) therapy in chronic oral lichen planus (OLP) have shown conflicting results. We report an investigator-blinded study of 13 patients with OLP, who were randomly assigned to treatment with CyA (500 mg as a swish-and-spit medication for 5 min three times daily) or a corticosteroid oral paste (triamcinolone acetonide). The duration of treatment was 6 weeks. Thereafter, patients on corticosteroid therapy were treated with CyA. Only slight, transient clinical improvement was observed in both groups after 6 weeks of treatment, compared with baseline. No significant differences could be demonstrated between the two groups. CyA therapy following corticosteroid treatment did not produce any further clinical improvement. During follow-up of the disease for up to 1 year after treatment, neither the CyA nor the corticosteroid group exhibited long-term improvement in disease activity. Contradictory results from earlier reports are discussed.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Review

MeSH terms

  • Administration, Topical
  • Adult
  • Aged
  • Cyclosporine / administration & dosage*
  • Female
  • Humans
  • Lichen Planus / drug therapy*
  • Male
  • Middle Aged
  • Mouth Diseases / drug therapy*
  • Prospective Studies
  • Triamcinolone Acetonide / therapeutic use

Substances

  • Cyclosporine
  • Triamcinolone Acetonide